Company intelligence
Nexus BioQuest
Driving innovative solutions in preclinical immunology
Research Services
Bristol, GB
38 employees
Founded 2022
6 public signals
About Nexus BioQuest
Driving innovative solutions in preclinical immunology
Verified activity
Signals from Nexus BioQuest
6 published signals
Presence & Recognition
Nexus BioQuest represented its Head of Business Development (Europe), Dr Anna Willox, at the SITC Europe Immuno-Oncology Drug Development Summit.
Reported by Nexus BioQuest
Research & Knowledge
Nexus BioQuest investigated whether immune complex-driven NETosis could be therapeutically modulated using freshly isolated human neutrophils.
Reported by Nexus BioQuest
Presence & Recognition
Nexus BioQuest spotlighted scRNAseq mapping the secondary lymphoid organ model at unprecedented resolution in August 2026.
Reported by Nexus BioQuest
Presence & Recognition
Nexus BioQuest joined the Health and Environmental Sciences Institute Cell and Gene Therapy Technical Committee (CGT-TRACS) in August 2026.
Reported by Nexus BioQuest
People
Nexus BioQuest welcomed Karina Di Gregoli, PhD to the Business Development team in August 2026.
Reported by Nexus BioQuest
People
Nexus BioQuest welcomed Isabel Atherton to the Sales and Marketing team in August 2026.
Reported by Nexus BioQuest